Overall, our findings suggested that HnRNP A1 - regulated aberrant alternative splicing of CCDC50 could contribute to the carcinogenesis and progression of ccRCC by modulating ZNF395. This evidence concerns the gene ZNF395 and nonpapillary renal cell carcinoma.